University of Turku, Turku, Finland.
Heart Unit, Satakunta Central Hospital, Pori, Finland.
Pharmacol Res Perspect. 2022 Jun;10(3):e00961. doi: 10.1002/prp2.961.
Low socioeconomic status has been associated with poor outcomes in patients with atrial fibrillation (AF). However, little is known about socioeconomic disparities in adherence to stroke prevention with direct oral anticoagulants (DOACs). We assessed the hypothesis that AF patients with higher income or educational levels have better adherence to DOACs in terms of treatment implementation and persistence. The used nationwide registry-based FinACAF cohort covers all patients with incident AF starting DOACs in Finland during 2011-2018. The implementation analyses included 74 222 (mean age 72.7 ± 10.5 years, 50.8% female) patients, and persistence analyses included 67 503 (mean age 75.3 ± 8.9 years, 53.6% female) patients with indication for permanent anticoagulation (CHA DS -VASc score >1 in men and >2 in women). Patients were divided into income quartiles and into three categories based on their educational attainment. Therapy implementation was measured using the medication possession ratio (MPR), and patients with MPR ≥0.90 were defined adherent. Persistence was measured as the incidence of therapy discontinuation, defined as the first 135-day period without DOAC purchases after drug initiation. Patients with higher income or education were consistently more likely adherent to DOACs in the implementation phase (comparing the highest income or educational category to the lowest: adjusted odds ratios 1.18 (1.12-1.25) and 1.21 (1.15-1.27), respectively). No association with income or educational levels was observed on the incidence of therapy discontinuation. In conclusion, we observed that income and educational levels both have independent positive association on the implementation of DOAC therapy but no association on therapy persistence in patients with AF.
社会经济地位低下与房颤(AF)患者的预后不良有关。然而,对于直接口服抗凝剂(DOAC)预防卒中的依从性方面的社会经济差异知之甚少。我们评估了以下假设,即收入或教育水平较高的 AF 患者在 DOAC 治疗的实施和持续方面具有更好的依从性。所使用的基于全国范围登记的 FinACAF 队列涵盖了 2011 年至 2018 年期间在芬兰开始使用 DOAC 的所有新发 AF 患者。实施分析包括 74222 名(平均年龄 72.7±10.5 岁,50.8%为女性)患者,持续分析包括 67503 名(平均年龄 75.3±8.9 岁,53.6%为女性)具有永久性抗凝指征的患者(CHA2DS2-VASc 评分男性>1,女性>2)。患者被分为收入四分位数,并根据其教育程度分为三个类别。通过药物使用比例(MPR)衡量治疗实施情况,MPR≥0.90 的患者被定义为依从性良好。将停药定义为起始药物治疗后 135 天内首次无 DOAC 购买,以此作为衡量持续性的指标。在实施阶段,收入或教育程度较高的患者更有可能使用 DOAC(与最低收入或教育程度类别相比,最高收入或教育程度类别:调整后的优势比分别为 1.18(1.12-1.25)和 1.21(1.15-1.27))。收入或教育程度与停药发生率之间无相关性。总之,我们观察到收入和教育程度均与 AF 患者 DOAC 治疗的实施有独立的积极关联,但与治疗持续时间无关联。